Skip to Content

News: January, 2021

A protein that can melt tumors discovered at Vanderbilt

Wednesday, January 27th, 2021

For the second time, cancer researchers at Vanderbilt have discovered a protein that—when genetically manipulated to impede it from interacting with a gene responsible for cancer genesis—effectively melts tumors in days.

An interacting factor in leukemia

Monday, January 25th, 2021

TG-Interacting Factor 1 (TGIF1) is a protein that regulates self-renewal of hematopoietic stem cells, which give rise to other blood cells, and which affects proliferation and differentiation of myeloid cells.

VUMC, Case Western apply artificial intelligence to “customize” oral cancer treatment

Tuesday, January 5th, 2021

Researchers at Vanderbilt University Medical Center and Case Western Reserve University in Cleveland have been awarded a five-year, $3.3 million grant by the National Cancer Institute to apply artificial intelligence (AI) to help customize treatment for oral cancer patients.